Literature DB >> 14675762

Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23.

W Meder1, M Wendland, A Busmann, C Kutzleb, N Spodsberg, H John, R Richter, D Schleuder, M Meyer, W G Forssmann.   

Abstract

The orphan receptor ChemR23 is a G-protein coupled receptor (GPCR) with homology to neuropeptide and chemoattractant receptors. Tazarotene, a synthetic retinoid activating retinoic acid receptor (RAR), up-regulates tazarotene-induced gene-2 (TIG2). The function and molecular target of this protein are now described. By means of reverse pharmacology screening using a peptide library generated from human hemofiltrate, we have isolated and identified TIG2 as the natural ligand of ChemR23 and report the specific molecular form of the bioactive, circulating TIG2, representing the amino-acid residues 21 to 154 of the 163 amino acid-containing prepropeptide. Based on the expression pattern of ChemR23 and TIG2, the physiological role in bone development, immune and inflammatory responses and the maintenance of skin is now being investigated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675762     DOI: 10.1016/s0014-5793(03)01312-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  76 in total

1.  Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma.

Authors:  Lei Zhao; Yasuto Yamaguchi; Shadi Sharif; Xiao-Yan Du; Jason J Song; David M Lee; Lawrence D Recht; William H Robinson; John Morser; Lawrence L K Leung
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Up-regulation of the chemo-attractive receptor ChemR23 and occurrence of apoptosis in human chondrocytes isolated from fractured calcaneal osteochondral fragments.

Authors:  Paola Sena; Giuseppe Manfredini; Marta Benincasa; Francesco Mariani; Alberto Smargiassi; Fabio Catani; Carla Palumbo
Journal:  J Anat       Date:  2014-04-01       Impact factor: 2.610

Review 3.  New methods for researching accessory proteins.

Authors:  Steven M Foord; Simon D Topp; Marco Abramo; Joanna D Holbrook
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  The genetic design of signaling cascades to record receptor activation.

Authors:  Gilad Barnea; Walter Strapps; Gilles Herrada; Yemiliya Berman; Jane Ong; Brian Kloss; Richard Axel; Kevin J Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-28       Impact factor: 11.205

5.  Chemerin C9 peptide induces receptor internalization through a clathrin-independent pathway.

Authors:  Jun-xian Zhou; Dan Liao; Shuo Zhang; Ni Cheng; Hui-qiong He; Richard D Ye
Journal:  Acta Pharmacol Sin       Date:  2014-03-24       Impact factor: 6.150

6.  Proteolytic cleavage of chemerin protein is necessary for activation to the active form, Chem157S, which functions as a signaling molecule in glioblastoma.

Authors:  Yasuto Yamaguchi; Xiao-Yan Du; Lei Zhao; John Morser; Lawrence L K Leung
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

7.  Chemerin-derived peptide C-20 suppressed gonadal steroidogenesis.

Authors:  Lei Li; Chen Huang; Xu Zhang; Jiangbo Wang; Ping Ma; Yongjun Liu; Tianxia Xiao; Brian A Zabel; Jian V Zhang
Journal:  Am J Reprod Immunol       Date:  2013-10-12       Impact factor: 3.886

8.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 9.  Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.

Authors:  Teizo Yoshimura; Joost J Oppenheim
Journal:  Exp Cell Res       Date:  2010-11-04       Impact factor: 3.905

Review 10.  Proteolytic regulatory mechanism of chemerin bioactivity.

Authors:  Xiao-Yan Du; Lawrence L K Leung
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2009-12       Impact factor: 3.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.